Skip to content
ppharmaranks
Menu
Class IICompleted

Estradiol Gel recall

FDA recall D-0246-2025 · initiated Feb 6, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 5, 2025How we research

Padagis US LLC recalled Estradiol Gel in Feb 2025 — an FDA Class II recall (D-0246-2025) because Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # 193109; Exp. 07/31/2026

Quantity recalled: 4944 cartons

Details

Product
Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30
Recalling company
Padagis US
Classification
Class II
Status
Completed
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Feb 6, 2025
FDA report date
Mar 5, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Estradiol Gel recalled?
Padagis US LLC recalled Estradiol Gel in Feb 2025 — an FDA Class II recall (D-0246-2025) because Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Estradiol Gel recalled?
Per the FDA enforcement record, the reason for recall D-0246-2025 was: Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.
Is a recalled Estradiol Gel dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Estradiol Gel are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot # 193109; Exp. 07/31/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0246-2025.

Source: openFDA Drug Enforcement record D-0246-2025

← All drug recalls